作者: A. Ali , J.R. Goffin , A. Arnold , P.M. Ellis
DOI: 10.3747/CO.20.1481
关键词: Overall survival 、 Retrospective cohort study 、 Internal medicine 、 Chemotherapy 、 Median survival 、 Cohort 、 Medicine 、 Surgery 、 Lung cancer 、 In patient 、 Oncology 、 Non small cell
摘要: Background The prognosis of patients with brain metastases from non-small-cell lung cancer (nsclc) is poor. However, some reports suggest that at the time initial diagnosis have a more favourable survival than do advanced nsclc without metastases. Methods In retrospective cohort all new seen Canadian tertiary centre between July 2005 and June 2007, we examined after for who developed later in their illness. Results During 2-year period, 91 878 (10.4%) Median age this was 64 years. 45, were present diagnosis, 46, course entire 7.8 months. Survival similar illness (4.8 months vs. 3.7 months, p = 0.53). As result, had longer overall did (9.8 4.8 months). Among received chemotherapy, still poor (6.2 Conclusions Our data show limited nsclc. Careful patient selection aggressive treatment approaches necessary.